GEN Exclusives

More »

Mar. 1, Vol. 26, No. 5

    • Point of View

      • Good News on Medicines but Bad Rap for Drug Makers
      • These are turbulent times for the pharmaceutical industry and its regulator, the FDA. Lately, both have focused increasingly on issues of safety. First there were claims that the labeling of certain antidepressants failed to warn doctors that the d ... more »
    • Legal Affairs

      • Pitfalls in Patenting of Biomolecules
      • Patents have always been an important tool for pharmaceutical and biotechnology companies to protect their biopharmaceutical products from competition. The composition patents for many basic biopharmaceutical products have expired or will expire soo ... more »
    • Wall Street BioBeat

      • M&As as Important Development Tools
      • The corporate merger (combining two businesses into one, usually by means of the initiating company paying for the transaction with its shares so that the shareholders of the target are now part-owners of the combined entity) or acquisition (the com ... more »
    • FDA News and Analysis

      • Finding a Balance in Assessment of Risk
      • Today the problem of deciding the case for approval is fraught with intense yet supposedly unknowable perils. The FDA and other regulatory agencies globally struggle with ambiguities that typify the review process for routine submissions to the exte ... more »
    • Feature Articles

      • Clearing the Target Validation Bottleneck
      • The target validation step of the drug discovery process aims to prove that a given target is directly involved in disease and can be used for development of a therapeutic drug. Validation of a target requires collection and comprehension of a wide ... more »
      • Corporate Profile: Beckman Removes Divisional Barriers
      • Beckman Coulter (www.beckmancoulter.com) has just completed a restructuring that is pulling down the divisional walls between biomedical research and clinical diagnostics, says Jeff Chapman, business manager, proteomics. The changes are expected to ... more »
      • ELN and LIMS Aid Biotechnology Growth
      • Paper documentation of data and processes, which has been integral to R&D labs for years continues to be a widely used tool for data capture and analysis, recording important inventions and archiving information. However, companies in the busine ... more »
      • LabAutomation 2006 Final Recap
      • More than 4,000 people gathered for LabAutomation 2006 as the Association for Laboratory Automation brought its 10th annual conference back to Palm Springs. Held at the end of January, the conference was, as usual, replete with new product introduct ... more »
      • M&As as Important Development Tools
      • The corporate merger (combining two businesses into one, usually by means of the initiating company paying for the transaction with its shares so that the shareholders of the target are now part-owners of the combined entity) or acquisition (the com ... more »
      • Protein Arrays as Key Discovery Tools
      • Drug development is such a formidable challenge that, some believe, it can only be undertaken effectively by big pharma. Time-consuming and expensive, the classic approach has been to screen vast numbers of low molecular weight compounds for efficac ... more »
      • Purification Woes Upstage Upstream Gains
      • New technologies in upstream biopharmaceutical production continue to increase yields and protein product quantities at the bioreactor. However, these higher titers, larger yields, and shorter production times are not always making it through as end ... more »
      • QA/QC for Viral Clearance
      • Gail Dutton
      • Viral clearance processes and the issues surrounding them are becoming more sophisticated but, as yet, few clear trends are emerging. However, industry experts are noting some currents and eddies that are beginning to swirl around the issue. For ex ... more »
    • Tutorials

      • Achieving Low-Volume Liquid Handling
      • Incorporating new liquid-handling technologies into the drug discovery process has been key to keeping pace with the demands for ever-increasing throughput and lower costs. Systems must be designed to cope with the sheer number of assays and novel c ... more »
      • Cell-Based Assays for Study of GPCRs
      • G-protein-coupled receptors (GPCRs) are among the most successful targets for drug discovery research. They represent the largest family of cell surface receptors with approximately 400 in the druggable genome. GPCRs are essential in the transmissio ... more »
      • Choosing & Scaling Up Right Filter Combo
      • Filter train selection and scaling trials with small-scale flat-disc composites have become routine. Such trials are often used to evaluate the optimal filter combination, polymer, and required retentivity. However, trials performed with a low effec ... more »

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?